Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Terminated1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01604031Phase 1Terminated
Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
B-cell Chronic Lymphocytic Leukemia
Principalinvestigator
NCT02291848Phase 1Active Not Recruiting
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
Multiple Myeloma
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Baylor College of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Moderately Similar
26 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score30%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Moderately Similar
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score30%

Arnon Nagler, MD

Chaim Sheba Medical Center

Moderately Similar
12 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score30%

Yves Beguin, MD, PhD

CHU-ULg

Moderately Similar
7 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellMultiple Myeloma
Similarity Score30%

Michael B Gill

Power Life Sciences Inc.

Moderately Similar
105 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellMultiple Myeloma
Similarity Score30%

David Avigan, MD

Beth Israel Deaconess Medical Center

Moderately Similar
17 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score30%

Agostino Tafuri

AOU Sant'Andrea

Related
1 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-Cell
Similarity Score15%

Laura Nocilli

Ospedale Papardo

Related
1 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-Cell
Similarity Score15%

Vincenzo Fraticelli

Responsible Research Hospital

Related
1 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-Cell
Similarity Score15%

Roberta Murru

Ospedale Oncologico" A. Businco" - ARNAS "G. Brotzu"

Related
1 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-Cell
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01604031Phase 1PrincipalInvestigator

Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide

B-cell Chronic Lymphocytic Leukemia
Terminated
NCT02291848Phase 1PrincipalInvestigator

Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

Multiple Myeloma
Active Not Recruiting

All 2 trials loaded